In	O	ADP	O
primary	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
CD28	B-protein	NOUN	B
ligation	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
rapid	O	ADJ	O
intracellular	O	ADJ	B
formation	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediates	O	NOUN	I
(	O	PUNCT	O
ROIs	O	NOUN	B
)	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
CD28	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
/	O	PUNCT	O
CD28-responsive	B-protein	ADJ	B
complex	I-protein	NOUN	I
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
therapeutic	O	ADJ	B
strategies	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
immunosuppressants	O	NOUN	B
targeting	O	VERB	B
the	O	DET	O
CD28	B-protein	NOUN	B
costimulatory	O	ADJ	I
pathway	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
differences	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
enhancer/promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
HIV-2	O	NOUN	B
functions	O	VERB	B
quite	O	ADV	B
differently	O	ADV	I
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
following	O	VERB	O
T-cell	O	NOUN	B
stimulation	O	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
largely	O	ADV	O
through	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
to	O	PART	O
two	O	NUM	O
adjacent	O	ADJ	B
kappa	B-DNA	NOUN	O
B	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
four	O	NUM	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
:	O	PUNCT	O
a	O	DET	O
single	O	ADJ	B
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
purine-rich	B-DNA	ADJ	B
binding	I-DNA	VERB	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
PuB1	B-DNA	NOUN	B
and	O	CCONJ	O
PuB2	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
pets	B-DNA	NOUN	B
site	I-DNA	NOUN	O
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
description	O	NOUN	B
of	O	ADP	O
an	O	DET	O
HIV-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	B
element	I-DNA	NOUN	I
which	O	DET	O
displays	O	VERB	O
such	O	ADJ	O
monocyte	O	NOUN	B
specificity	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
no	O	DET	O
comparable	O	ADJ	O
enhancer	B-DNA	NOUN	B
element	I-DNA	NOUN	I
has	O	AUX	O
been	O	AUX	O
clearly	O	ADV	O
defined	O	VERB	O
for	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


E1A	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
induces	O	VERB	O
susceptibility	O	NOUN	B
to	O	PART	O
killing	O	VERB	B
by	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
following	O	VERB	O
immortalization	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
adenovirus	O	NOUN	B
infection	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Adenovirus	O	NOUN	B
(	O	PUNCT	O
Ad	O	NOUN	B
)	O	PUNCT	O
infection	O	NOUN	O
and	O	CCONJ	O
E1A	B-protein	NOUN	B
transfection	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
model	O	VERB	B
changes	O	NOUN	B
in	O	ADP	O
susceptibility	O	NOUN	B
to	O	PART	O
NK	O	NOUN	B
cell	O	NOUN	I
killing	O	NOUN	B
caused	O	VERB	O
by	O	ADP	O
transient	O	ADJ	B
vs	O	CCONJ	O
stable	O	ADJ	O
E1A	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
E1A	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
products	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
cytolytic	O	ADJ	B
susceptibility	O	NOUN	I
during	O	ADP	O
infection	O	NOUN	B
was	O	AUX	O
not	O	PART	O
explained	O	VERB	O
by	O	ADP	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
viral	O	ADJ	B
infection	O	NOUN	I
on	O	ADP	O
otherwise	O	ADV	O
susceptible	O	ADJ	B
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
effects	O	NOUN	O
on	O	ADP	O
class	B-protein	NOUN	B
I	I-protein	NUM	I
MHC	I-protein	NOUN	I
antigen	I-protein	NOUN	I
expression	O	NOUN	B
on	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
CD4	B-protein	NOUN	B
triggering	O	NOUN	B
on	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activating	O	NOUN	O
signals	O	NOUN	B
in	O	ADP	O
a	O	DET	O
lymphoma	O	NOUN	B
model	O	NOUN	I
using	O	VERB	O
monoclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
(	O	PUNCT	O
mAb	B-protein	NOUN	B
)	O	PUNCT	O
which	O	DET	O
recognize	O	VERB	O
different	O	ADJ	O
CD4	B-protein	NOUN	B
epitopes	I-protein	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
different	O	ADJ	O
anti-CD4	B-protein	ADJ	B
mAb	I-protein	NOUN	B
or	O	CCONJ	O
HIV-1	B-protein	NOUN	B
gp120	I-protein	NOUN	B
could	O	AUX	O
all	O	DET	O
trigger	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
p56lck	B-protein	NOUN	I
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Shc	B-protein	NOUN	B
adaptor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mediates	O	VERB	O
signals	O	NOUN	B
to	O	PART	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
differed	O	VERB	O
significantly	O	ADV	O
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
activate	O	VERB	B
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
identify	O	VERB	O
functionally	O	ADV	O
distinct	O	ADJ	O
epitopes	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ras/protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
calcium	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
chickens	O	NOUN	B
,	O	PUNCT	O
estrogens	O	NOUN	B
stimulate	O	VERB	O
outgrowth	O	NOUN	B
of	O	ADP	O
bone	B-cell_type	NOUN	B
marrow-derived	I-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	I
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
delay	O	VERB	B
their	O	PRON	O
maturation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
estrogens	O	NOUN	B
also	O	ADV	O
reduce	O	VERB	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
erythroid	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
primary	B-cell_line	ADJ	O
human	I-cell_line	ADJ	B
bone	I-cell_line	NOUN	O
marrow	I-cell_line	NOUN	O
cultures	I-cell_line	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
repressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
ER	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
repression	O	NOUN	B
is	O	AUX	O
reversible	O	ADJ	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
4-hydroxytamoxifen	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
coimmunoprecipitation	O	NOUN	B
experiments	O	NOUN	I
using	O	VERB	O
transfected	O	VERB	B
COS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
ER	B-protein	NOUN	B
associate	O	VERB	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
speculate	O	VERB	O
that	O	SCONJ	O
estrogens	O	NOUN	B
exert	O	VERB	O
effects	O	NOUN	B
on	O	ADP	O
erythropoiesis	O	NOUN	B
by	O	ADP	O
modulating	O	VERB	O
GATA-1	B-protein	NOUN	B
activity	O	NOUN	B
through	O	ADP	O
protein-protein	O	ADJ	B
interaction	O	NOUN	I
with	O	ADP	O
the	O	DET	O
ER	B-protein	NOUN	B
.	O	PUNCT	O


Interleukin-1	B-protein	NOUN	B
and	O	CCONJ	O
interleukin-2	B-protein	NOUN	B
control	O	VERB	O
transcription	O	NOUN	O
via	O	ADP	O
distinct	O	ADJ	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
map	O	VERB	B
the	O	DET	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
that	O	PRON	O
mediate	O	VERB	O
interleukin	O	NOUN	B
responsiveness	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
IL-2R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
using	O	VERB	O
a	O	DET	O
thymic	B-cell_line	ADJ	B
lymphoma-derived	I-cell_line	ADJ	I
hybridoma	I-cell_line	NOUN	I
(	O	PUNCT	O
PC60	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


It	O	PRON	O
also	O	ADV	O
primes	O	VERB	B
cells	O	NOUN	I
to	O	PART	O
become	O	VERB	O
IL-2	B-protein	NOUN	B
responsive	O	ADJ	B
and	O	CCONJ	O
thereby	O	ADV	O
prepares	O	VERB	O
the	O	DET	O
second	O	ADJ	O
phase	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
IL-2	B-protein	NOUN	B
induces	O	VERB	B
a	O	DET	O
100-fold	O	ADV	O
further	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
IL-2R	B-RNA	NOUN	B
alpha	I-RNA	NOUN	O
transcripts	I-RNA	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
show	O	VERB	O
that	O	SCONJ	O
several	O	ADJ	O
elements	O	NOUN	B
in	O	ADP	O
the	O	DET	O
promoter-proximal	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
contribute	O	VERB	O
to	O	PART	O
IL-1	B-protein	NOUN	B
responsiveness	O	NOUN	B
,	O	PUNCT	O
most	O	ADV	O
importantly	O	ADV	O
an	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
conserved	O	VERB	O
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
mouse	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
segment	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
an	O	DET	O
IL-2-inducible	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
lies	O	VERB	O
within	O	ADP	O
a	O	DET	O
region	O	NOUN	B
that	O	PRON	O
becomes	O	VERB	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
hypersensitive	O	ADJ	B
in	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
which	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


Hematopoietic	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	O
commitment	O	NOUN	B
:	O	PUNCT	O
role	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
review	O	NOUN	B
focuses	O	VERB	O
on	O	ADP	O
the	O	DET	O
roles	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
hematopoietic	O	ADJ	B
lineage	O	NOUN	I
commitment	O	NOUN	B
.	O	PUNCT	O


Next	O	ADV	O
is	O	AUX	O
presented	O	VERB	O
a	O	DET	O
discussion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
embryonic	B-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
hematopoietic	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
expression	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
targeted	O	VERB	B
gene	O	NOUN	B
disruption	O	NOUN	B
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
hematopoiesis	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
replicative	O	ADJ	B
gene	O	NOUN	B
transcription	O	NOUN	I
during	O	ADP	O
de	O	X	B
novo	O	X	I
infection	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
thymocytes	I-cell_type	NOUN	B
:	O	PUNCT	O
simultaneous	O	ADJ	B
early	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
BZLF-1	B-protein	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
repressor	O	NOUN	B
RAZ	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
and	O	CCONJ	O
others	O	NOUN	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
EBV	O	NOUN	B
can	O	AUX	O
also	O	ADV	O
infect	O	VERB	B
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Circularization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EBV	B-DNA	NOUN	B
genome	I-DNA	NOUN	B
was	O	AUX	O
not	O	PART	O
detected	O	VERB	B
.	O	PUNCT	O


Transcripts	O	NOUN	B
encoding	O	VERB	B
gp350/220	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
major	B-protein	ADJ	O
coat	I-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
EBV	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
we	O	PRON	O
did	O	AUX	O
not	O	PART	O
find	O	VERB	O
any	O	DET	O
evidence	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
LMP-2A	B-DNA	NOUN	B
or	O	CCONJ	O
EBER-1	B-DNA	NOUN	B
loci	I-DNA	NOUN	I
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
de	O	X	B
novo	O	X	I
EBV	O	NOUN	B
infection	O	NOUN	B
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
differs	O	VERB	O
from	O	ADP	O
infection	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
and	O	CCONJ	O
purification	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
Stat	I-protein	NOUN	B
proteins	I-protein	NOUN	I
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
interleukin-2	B-protein	NOUN	B
.	O	PUNCT	O


Several	O	ADJ	O
recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
implicated	O	VERB	O
Jak	O	NOUN	B
kinases	O	NOUN	I
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
were	O	AUX	O
observed	O	VERB	O
to	O	PART	O
contain	O	VERB	O
several	O	ADJ	O
IL-2	B-protein	NOUN	B
-inducible	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
activities	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
hypothesize	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
hStat5	B-protein	NOUN	B
,	O	PUNCT	O
helps	O	VERB	O
govern	O	VERB	O
the	O	DET	O
biological	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
during	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
,	O	PUNCT	O
through	O	ADP	O
the	O	DET	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
UDG	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
,	O	PUNCT	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
E2F-1	B-protein	NOUN	B
activates	O	VERB	B
the	O	DET	O
UDG	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
through	O	ADP	O
several	O	ADJ	O
E2F	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
cyclin-like	B-protein	ADJ	B
UDG	I-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
and	O	CCONJ	O
E2F	B-protein	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
UDG	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
transient	O	ADJ	B
transfection	O	NOUN	O
assay	O	NOUN	O
result	O	VERB	O
in	O	ADP	O
the	O	DET	O
down-regulation	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
through	O	ADP	O
elements	B-DNA	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
E2F	B-protein	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
.	O	PUNCT	O


Cellular	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
production	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
NK	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
immunoregulatory	B-protein	ADJ	B
protein	I-protein	NOUN	I
produced	O	VERB	O
predominantly	O	ADV	O
by	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
large	B-cell_type	ADJ	O
granular	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	O
(	O	PUNCT	O
LGL	B-cell_type	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
different	O	ADJ	O
extracellular	O	ADJ	B
signals	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
new	O	ADJ	O
protein	O	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
IL-2	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
GM-CSF	I-RNA	NOUN	B
cytoplasmic	I-RNA	ADJ	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
both	O	CCONJ	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor-beta	I-protein	NOUN	I
and	O	CCONJ	O
genistein	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
could	O	AUX	O
suppress	O	VERB	B
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	B
but	O	CCONJ	O
CsA	O	NOUN	B
was	O	AUX	O
generally	O	ADV	O
inactive	O	ADJ	B
.	O	PUNCT	O


It	O	PRON	O
also	O	ADV	O
was	O	AUX	O
observed	O	VERB	O
that	O	SCONJ	O
suppression	O	NOUN	B
of	O	ADP	O
cytokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
was	O	AUX	O
independent	O	ADJ	B
of	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
proliferation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
distinct	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
NK3.3	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
may	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
model	O	NOUN	B
for	O	ADP	O
dissecting	O	VERB	B
the	O	DET	O
biochemical	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
events	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
these	O	DET	O
pathways	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
functional	O	ADJ	B
T-cell	B-protein	NOUN	O
receptor	I-protein	NOUN	O
signaling	O	NOUN	O
pathway	O	NOUN	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
p95vav	B-protein	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
substrate	O	NOUN	B
is	O	AUX	O
p95vav	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
exclusively	O	ADV	O
in	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
trophoblast	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
structural	B-protein	ADJ	B
motifs	I-protein	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
Src	B-protein	NOUN	B
homology	I-protein	NOUN	B
2	I-protein	NUM	I
,	I-protein	PUNCT	O
Src	I-protein	NOUN	B
homology	I-protein	NOUN	O
3	I-protein	NUM	O
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
pleckstrin	I-protein	NOUN	B
homology	I-protein	NOUN	I
domains	I-protein	NOUN	I
and	O	CCONJ	O
a	O	DET	O
putative	B-protein	ADJ	B
guanine	I-protein	NOUN	I
nucleotide	I-protein	NOUN	I
exchange	I-protein	NOUN	I
domain	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
p95vav	B-protein	NOUN	B
synergizes	O	VERB	B
with	O	ADP	I
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
inducing	O	VERB	O
NFAT-	O	NOUN	B
and	O	CCONJ	O
interleukin-2-dependent	O	ADJ	B
transcription	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
removal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
first	B-protein	ADJ	O
67	I-protein	NUM	O
amino	I-protein	NOUN	B
acids	I-protein	NOUN	I
of	O	ADP	O
p95vav	B-protein	NOUN	B
activates	O	VERB	B
its	O	PRON	O
transforming	O	VERB	B
potential	O	NOUN	I
in	O	ADP	O
NIH	B-cell_line	NOUN	B
3T3	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
this	O	DET	O
region	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
its	O	PRON	O
function	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
p95vav	B-protein	NOUN	B
-induced	O	ADJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
not	O	PART	O
mimicked	O	VERB	O
by	O	ADP	O
Ras	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
though	O	SCONJ	O
its	O	PRON	O
function	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
Ras	B-protein	NOUN	B
and	O	CCONJ	O
Raf	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
p95vav	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
influence	O	VERB	B
TCR	B-protein	NOUN	B
-induced	O	ADJ	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
or	O	CCONJ	O
increases	O	VERB	B
in	O	ADP	O
cytoplasmic	O	ADJ	B
free	O	ADJ	I
calcium	O	NOUN	I
.	O	PUNCT	O


Positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
promoter	O	NOUN	B
activity	O	NOUN	I
by	O	ADP	O
AML1-related	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
PEBP2	B-protein	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
alpha	B-DNA	NOUN	B
A	I-DNA	NOUN	I
and	O	CCONJ	O
alpha	B-DNA	NOUN	B
B	I-DNA	NOUN	I
,	O	PUNCT	O
encoding	O	VERB	B
the	O	DET	O
alpha	B-protein	NOUN	B
subunit	I-protein	NOUN	I
.	O	PUNCT	O


PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	I
A1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
enhanced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter-driven	I-DNA	ADJ	B
reporter	I-DNA	NOUN	I
plasmid	I-DNA	NOUN	I
in	O	ADP	O
unstimulated	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
12-O-tetradecanoylphorbol	I-cell_line	NOUN	O
13-acetate/phytohemagglutinin-stimulated	I-cell_line	ADJ	O
human	I-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B2	I-protein	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
/alpha	B-protein	NOUN	I
B2	I-protein	NOUN	I
ratio	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
further	O	ADJ	O
studies	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
precise	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
PEBP2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
GM-CSF	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
present	O	ADJ	O
findings	O	NOUN	B
suggested	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
relative	O	ADJ	O
ratio	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
PEBP2	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
in	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
/	O	PUNCT	O
macrophages	B-cell_type	NOUN	B
by	O	ADP	O
bacterial	B-protein	ADJ	B
endotoxin	I-protein	NOUN	B
or	O	CCONJ	O
lipopolysaccharide	O	NOUN	B
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	B
,	O	PUNCT	O
highly	O	ADV	O
regulated	O	VERB	O
host	O	NOUN	B
defence	O	NOUN	B
response	O	NOUN	I
.	O	PUNCT	O


IFN-gamma	B-protein	NOUN	B
pre-treatment	O	NOUN	B
affected	O	VERB	B
the	O	DET	O
magnitude	O	NOUN	B
rather	O	ADV	O
than	O	ADP	O
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
LPS	O	NOUN	B
response	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
transcriptional	O	ADJ	B
rate	O	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
a	O	DET	O
marked	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
using	O	VERB	O
a	O	DET	O
consensus	B-DNA	NOUN	B
NF-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
oligonucleotide	I-DNA	NOUN	I
.	O	PUNCT	O


An	O	DET	O
additional	O	ADJ	O
significant	O	ADJ	O
finding	O	NOUN	B
was	O	AUX	O
than	O	ADP	O
TNF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
induced	O	VERB	B
in	O	ADP	O
primed	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
much	O	ADV	O
more	O	ADV	O
stable	O	ADJ	B
than	O	ADP	O
in	O	ADP	O
unprimed	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
T1/2	O	NOUN	B
increased	O	VERB	B
6-8-fold	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
increased	O	VERB	B
mRNA	B-RNA	NOUN	B
stability	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
duration	O	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
accumulation	O	NOUN	B
was	O	AUX	O
longer	O	ADJ	O
following	O	VERB	O
LPS	O	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
primed	O	VERB	B
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
being	O	AUX	O
of	O	ADP	O
greater	O	ADJ	O
magnitude	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
minimal	O	ADJ	B
CD4	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
has	O	AUX	O
four	O	NUM	O
factor	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
each	O	DET	O
of	O	ADP	O
which	O	DET	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
full	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
biochemical	O	ADJ	B
and	O	CCONJ	O
mutagenesis	O	NOUN	B
analyses	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
multiple	O	ADJ	B
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
bind	O	VERB	B
to	O	PART	O
these	O	DET	O
independent	O	ADJ	O
sites	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
believe	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MAZ	B-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
is	O	AUX	O
also	O	ADV	O
likely	O	ADJ	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
developmental	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TAL1	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
or	I-DNA	CCONJ	O
SCL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
originally	O	ADV	O
identified	O	VERB	B
through	O	ADP	O
its	O	PRON	O
involvement	O	NOUN	B
by	O	ADP	O
a	O	DET	O
recurrent	O	ADJ	B
chromosomal	O	ADJ	B
translocation	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
frequent	O	ADJ	B
molecular	O	ADJ	B
lesion	O	NOUN	I
recognized	O	VERB	O
in	O	ADP	O
T-cell	O	NOUN	B
acute	O	ADJ	I
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protein	B-protein	NOUN	B
products	I-protein	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
contain	O	VERB	O
the	O	DET	O
basic-helix-loop-helix	B-protein	ADJ	B
motif	I-protein	NOUN	I
characteristic	O	ADJ	I
of	O	ADP	O
a	O	DET	O
large	O	ADJ	O
family	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
canonical	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
CANNTG	I-DNA	NOUN	I
as	O	ADP	O
protein	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


Nonradioactive	O	ADJ	B
quantification	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
monocytic	B-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
U937	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
method	O	NOUN	B
for	O	ADP	O
relative	O	ADJ	O
quantification	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
mRNA	B-RNA	NOUN	B
using	O	VERB	O
a	O	DET	O
nonradioactive	O	ADJ	B
assay	O	NOUN	I
based	O	VERB	O
on	O	ADP	O
DNA	O	NOUN	B
strand	O	NOUN	I
competition	O	NOUN	B
between	O	ADP	O
identical	O	ADJ	B
sequences	O	NOUN	B
of	O	ADP	O
biotin-	O	NOUN	B
and	O	CCONJ	O
fluorescein-labeled	O	ADJ	B
amplicon	O	NOUN	I
(	O	PUNCT	O
probe	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
unlabeled	O	ADJ	B
amplicon	O	NOUN	I
(	O	PUNCT	O
target	O	NOUN	B
)	O	PUNCT	O
during	O	ADP	O
hybridization	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
technique	O	NOUN	B
was	O	AUX	O
successfully	O	ADV	O
applied	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
differences	O	NOUN	B
in	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
potent	O	ADJ	O
differentiation	O	NOUN	B
inducers	O	NOUN	B
:	O	PUNCT	O
12-O-tetradecanoylphorbol	O	NOUN	O
13-acetate	O	NOUN	O
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
all-trans	O	ADJ	B
retinoic	O	ADJ	I
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D2	O	NOUN	I
(	O	PUNCT	O
VD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
purely	O	ADV	O
enhancer-dependent	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
such	O	ADJ	O
as	O	ADP	O
TNF	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	O
region	I-DNA	NOUN	O
(	O	PUNCT	O
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
okadaic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
OKA	O	NOUN	B
)	O	PUNCT	O
activates	O	VERB	B
HIV	O	NOUN	B
transcription	O	NOUN	O
through	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
enhancer	O	NOUN	B
,	O	PUNCT	O
responding	O	VERB	B
to	O	PART	O
the	O	DET	O
factor	O	NOUN	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
promoter	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
both	O	CCONJ	O
transformed	B-cell_type	VERB	B
and	I-cell_type	CCONJ	O
normal	I-cell_type	ADJ	O
lymphocytes	I-cell_type	NOUN	O
,	O	PUNCT	O
OKA	O	NOUN	B
stimulation	O	NOUN	B
induced	O	VERB	B
intense	O	ADJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
constitutively	O	ADV	B
expressed	O	VERB	B
Sp1	B-protein	NOUN	B
protein	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
property	O	NOUN	O
of	O	ADP	O
OKA	O	NOUN	B
not	O	PART	O
shared	O	VERB	O
by	O	ADP	O
TNF	B-protein	NOUN	B
,	O	PUNCT	O
phorbol	O	NOUN	B
ester	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
PHA	B-protein	NOUN	B
and	O	CCONJ	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
.	O	PUNCT	O


Responsiveness	O	NOUN	B
of	O	ADP	O
LTR	B-DNA	NOUN	B
constructs	I-DNA	NOUN	B
deleted	O	VERB	O
of	O	ADP	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
to	O	PART	O
HIV	B-protein	NOUN	B
Tat	I-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
increased	O	VERB	B
upon	O	SCONJ	O
OKA	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
TNF	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
SP1	B-protein	NOUN	B
phosphorylation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
OKA	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
selective	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
serine-threonine	B-protein	ADJ	B
phosphatase	I-protein	NOUN	I
PP2A	B-protein	NOUN	B
,	O	PUNCT	O
facilitates	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
transcription	B-protein	NOUN	B
complex	I-protein	NOUN	I
involving	O	VERB	O
general	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
HIV	B-protein	NOUN	B
Tat	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
rapidly	O	ADV	O
activated	O	VERB	B
Stat5	B-protein	NOUN	B
in	O	ADP	O
fresh	O	ADJ	B
PBL	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Stat3	B-protein	NOUN	B
and	O	CCONJ	O
Stat5	B-protein	NOUN	B
in	O	ADP	O
preactivated	B-cell_type	ADJ	B
PBL	I-cell_type	NOUN	B
.	O	PUNCT	O


IL-7	B-protein	NOUN	B
and	O	CCONJ	O
IL-15	B-protein	NOUN	B
induced	O	VERB	B
the	O	DET	O
same	O	ADJ	O
complexes	O	NOUN	B
as	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
feature	O	NOUN	O
explained	O	VERB	O
by	O	ADP	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
similar	O	ADJ	O
tyrosine-phosphorylated	B-protein	ADJ	B
motifs	I-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domains	I-protein	NOUN	I
of	O	ADP	O
IL-2R	B-protein	NOUN	B
beta	I-protein	NOUN	B
and	O	CCONJ	O
IL-7R	B-protein	NOUN	B
that	O	PRON	O
can	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
docking	O	NOUN	B
sites	O	NOUN	I
for	O	ADP	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
single	O	ADJ	O
cytokine	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
different	O	ADJ	O
combinations	O	NOUN	B
of	O	ADP	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
under	O	ADP	O
different	O	ADJ	O
physiological	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
indicate	O	VERB	O
two	O	NUM	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
distinct	O	ADJ	O
cytokines	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
the	O	DET	O
same	O	ADJ	O
Stat	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Various	O	ADJ	O
stimuli	O	NOUN	B
,	O	PUNCT	O
typically	O	ADV	O
those	O	DET	O
associated	O	VERB	B
with	O	ADP	I
stress	O	NOUN	B
or	O	CCONJ	O
pathogens	O	NOUN	B
,	O	PUNCT	O
rapidly	O	ADV	O
inactivate	O	VERB	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
either	O	CCONJ	O
serine-32	O	NOUN	B
or	O	CCONJ	O
serine-36	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	O
was	O	AUX	O
mutated	O	VERB	B
,	O	PUNCT	O
the	O	DET	O
protein	O	NOUN	B
did	O	AUX	O
not	O	PART	O
undergo	O	VERB	O
signal-induced	O	ADJ	B
phosphorylation	O	NOUN	B
or	O	CCONJ	O
degradation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
activated	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
deletion	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
transfection	O	NOUN	B
assays	O	NOUN	I
with	O	ADP	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
constructs	I-DNA	NOUN	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
transcription	B-DNA	NOUN	B
control	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
EpoR	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
150	B-DNA	NUM	O
bp	I-DNA	NOUN	O
hEpoR	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
exhibited	O	VERB	O
high	O	ADJ	B
and	O	CCONJ	O
low	O	ADJ	O
activity	O	NOUN	B
in	O	ADP	O
erythroid	O	ADJ	B
OCIM1	B-cell_line	NOUN	I
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
reflecting	O	VERB	O
the	O	DET	O
high	O	ADJ	B
and	O	CCONJ	O
low	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
hEpoR	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
increasing	O	VERB	O
GATA-1	B-protein	NOUN	B
levels	O	NOUN	B
via	O	ADP	O
co-transfection	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transactivate	O	VERB	B
the	O	DET	O
hEpoR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
non-erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
highly	O	ADV	O
active	O	ADJ	O
OCIM1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
GATA-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
comparable	O	ADJ	O
in	O	ADP	O
OCIM1	B-cell_line	NOUN	B
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
while	O	SCONJ	O
GATA-1	B-protein	NOUN	B
can	O	AUX	O
transactivate	O	VERB	B
the	O	DET	O
EpoR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
hEpoR	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
does	O	AUX	O
not	O	PART	O
depend	O	VERB	O
on	O	ADP	O
GATA-1	B-protein	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
proteins	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
these	O	DET	O
two	O	NUM	O
latter	O	ADJ	O
genes	O	NOUN	B
is	O	AUX	O
approximately	O	ADV	O
65	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
includes	O	VERB	O
domains	O	NOUN	B
and	O	CCONJ	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
(	O	PUNCT	O
the	O	DET	O
leucine	B-protein	NOUN	B
zipper-like	I-protein	ADJ	B
and	O	CCONJ	O
the	O	DET	O
RGD	B-protein	NOUN	B
domain	I-protein	NOUN	O
,	O	PUNCT	O
a	O	DET	O
serine	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
histidine	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NH2-	B-protein	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
COOH-terminal	B-protein	ADJ	B
portion	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
postulated	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
nm23	B-protein	NOUN	B
function	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
interferon-gamma	B-DNA	NOUN	B
activation	I-DNA	NOUN	B
sequence	I-DNA	NOUN	O
mediates	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IgG	B-DNA	NOUN	B
Fc	I-DNA	NOUN	B
receptor	I-DNA	NOUN	I
type	I-DNA	NOUN	I
IC	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
by	O	ADP	O
interferon-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IgG	B-protein	NOUN	B
Fc	I-protein	NOUN	B
receptor	I-protein	NOUN	I
type	I-protein	NOUN	I
I	I-protein	NUM	I
(	O	PUNCT	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RI	I-protein	NOUN	I
)	O	PUNCT	O
on	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
dramatically	O	ADV	O
increased	O	VERB	B
by	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RI	I-protein	NOUN	I
transcript	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
monoblast-like	B-cell_line	ADJ	B
U937	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
elevated	O	ADJ	B
within	O	ADP	O
3	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
peaked	O	VERB	O
12	O	NUM	O
hr	O	NOUN	O
after	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Double-stranded	B-DNA	ADJ	B
GIRE	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
a	O	DET	O
scrambled	B-DNA	VERB	B
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
specifically	O	ADV	O
bound	O	VERB	O
by	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
from	O	ADP	O
IFN-gamma	B-cell_line	NOUN	B
treated	I-cell_line	ADJ	B
U937	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Fc	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
RIC	I-DNA	NOUN	I
GIRE	I-DNA	NOUN	B
is	O	AUX	O
homologous	O	ADJ	O
to	O	PART	O
the	O	DET	O
IFN-gamma	B-DNA	NOUN	B
activation	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
GAS	B-DNA	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
guanylate	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
and	O	CCONJ	O
to	O	PART	O
X	B-DNA	NOUN	O
box	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
of	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
MHC	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


HTLV-I-infected	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
exhibit	O	VERB	O
an	O	DET	O
initial	O	ADJ	B
phase	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
-dependent	O	ADJ	O
growth	O	NOUN	B
;	O	PUNCT	O
over	O	ADP	O
time	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
an	O	DET	O
unknown	O	ADJ	O
mechanism	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
cells	O	NOUN	B
become	O	VERB	O
IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
.	O	PUNCT	O


In	O	ADP	O
HTLV-I-infected	B-cell_line	ADJ	B
cord	I-cell_line	NOUN	I
blood	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
,	O	PUNCT	O
the	O	DET	O
transition	O	NOUN	B
from	O	ADP	O
IL-2	B-protein	NOUN	B
-dependent	O	ADJ	O
to	O	PART	O
IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
growth	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
acquisition	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
activated	O	VERB	B
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
pathway	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
pathway	O	NOUN	B
participates	O	VERB	O
in	O	ADP	O
HTLV-I-mediated	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
transformation	O	NOUN	O
.	O	PUNCT	O


Nitric	O	ADJ	B
oxide	O	NOUN	I
decreases	O	VERB	B
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
endothelial	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
concentration-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
NO	O	NOUN	B
inhibited	O	VERB	B
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
alpha-stimulated	O	ADJ	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
35-55	O	NUM	O
%	O	NOUN	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
cell	O	NOUN	B
surface	O	NOUN	I
enzyme	O	NOUN	B
immunoassays	O	NOUN	I
and	O	CCONJ	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


NO	O	NOUN	B
also	O	ADV	O
decreased	O	VERB	B
the	O	DET	O
endothelial	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
leukocyte	B-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
(	O	PUNCT	O
E-selectin	B-protein	NOUN	B
and	O	CCONJ	O
to	O	PART	O
a	O	DET	O
lesser	O	ADJ	B
extent	O	NOUN	B
,	O	PUNCT	O
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
secretable	O	ADJ	B
cytokines	B-protein	NOUN	I
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
and	O	CCONJ	O
IL-8	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Nuclear	O	ADJ	B
run-on	O	ADJ	I
assays	O	NOUN	I
,	O	PUNCT	O
transfection	O	NOUN	B
studies	O	NOUN	I
using	O	VERB	O
various	O	ADJ	O
VCAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
constructs	I-DNA	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
NO	O	NOUN	B
represses	O	VERB	B
VCAM-1	B-protein	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
by	O	ADP	O
inhibiting	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
also	O	ADV	O
induces	O	VERB	B
chemotaxis	O	NOUN	B
and	O	CCONJ	O
inflammatory	O	ADJ	B
responses	O	NOUN	I
in	O	ADP	O
mature	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
types	I-cell_type	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
important	O	ADJ	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
mechanisms	O	NOUN	B
which	O	DET	O
control	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
MIP-1	B-protein	NOUN	B
alpha	I-protein	NOUN	B
/GOS19	B-protein	NOUN	O
.	O	PUNCT	O


Previous	O	ADJ	O
work	O	NOUN	O
has	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
widely	O	ADV	O
expressed	O	VERB	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
the	O	DET	O
ICK-1	B-protein	NOUN	B
family	I-protein	NOUN	O
)	O	PUNCT	O
affect	O	VERB	O
the	O	DET	O
GOS19	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
communication	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
pathway	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
macrophage	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U937	B-cell_line	NOUN	O
is	O	AUX	O
different	O	ADJ	O
from	O	ADP	O
that	O	DET	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
an	O	DET	O
additional	O	ADJ	O
binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
,	O	PUNCT	O
the	O	DET	O
MIP-1	B-DNA	NOUN	B
alpha	I-DNA	NOUN	B
nuclear	I-DNA	ADJ	I
protein	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
MNP	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
site	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
overlaps	O	VERB	O
the	O	DET	O
ICK-1	B-DNA	NOUN	B
site	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MNP	B-DNA	NOUN	B
site	I-DNA	NOUN	B
which	O	DET	O
does	O	AUX	O
not	O	PART	O
abrogate	O	VERB	O
ICK-1	O	NOUN	B
binding	O	NOUN	B
inactivates	O	VERB	B
the	O	DET	O
GOS19.1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
reduces	O	VERB	B
its	O	PRON	O
activity	O	NOUN	B
by	O	ADP	O
fourfold	O	ADV	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MNP	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
binding	O	NOUN	B
at	O	ADP	O
the	O	DET	O
MNP	B-DNA	NOUN	B
site	I-DNA	NOUN	B
constitutes	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
expressed	O	VERB	B
in	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Toremifene	O	NOUN	B
exerts	O	VERB	O
multiple	O	ADJ	B
and	O	CCONJ	O
varied	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	O
mononuclear	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
interleukin-5	B-protein	NOUN	B
/receptor	O	NOUN	O
interaction	O	NOUN	B
activates	O	VERB	B
Lyn	B-protein	NOUN	B
and	I-protein	CCONJ	O
Jak2	I-protein	NOUN	B
tyrosine	I-protein	NOUN	B
kinases	I-protein	NOUN	I
and	O	CCONJ	O
propagates	O	VERB	B
signals	O	NOUN	B
via	O	ADP	O
the	O	DET	O
Ras-Raf-1-MAP	B-protein	NOUN	B
kinase	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
pathways	O	NOUN	I
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


IL-5	B-protein	NOUN	B
also	O	ADV	O
stimulates	O	VERB	B
GTP	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
p21ras	B-protein	NOUN	B
.	O	PUNCT	O


Jak2	B-protein	NOUN	B
kinase	I-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
phosphorylate	O	VERB	B
STAT	B-protein	NOUN	B
nuclear	I-protein	ADJ	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IE2	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
of	O	ADP	O
human	O	ADJ	B
cytomegalovirus	O	NOUN	I
(	O	PUNCT	O
HCMV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
a	O	DET	O
few	O	ADJ	O
viral	B-protein	ADJ	B
regulatory	I-protein	ADJ	O
proteins	I-protein	NOUN	O
expressed	O	VERB	B
immediately	O	ADV	O
upon	O	SCONJ	O
infection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
host	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
transcriptional	B-protein	ADJ	B
activator	I-protein	NOUN	I
of	O	ADP	O
many	O	ADJ	O
viral	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
cellular	I-DNA	ADJ	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
unlike	O	ADP	O
another	O	DET	O
tumor	B-protein	NOUN	B
suppressor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
p53	B-protein	NOUN	B
,	O	PUNCT	O
Rb	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
have	O	AUX	O
any	O	DET	O
significant	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
basal	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
Rb	B-protein	NOUN	B
specifically	O	ADV	O
interacts	O	VERB	O
with	O	ADP	O
IE2	B-protein	NOUN	B
rather	O	ADV	O
than	O	ADP	O
other	O	ADJ	O
cellular	B-protein	ADJ	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
general	O	ADJ	B
transcription	O	NOUN	I
machinery	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
Rb	B-protein	NOUN	B
may	O	AUX	O
regulate	O	VERB	B
the	O	DET	O
life	O	NOUN	B
cycle	O	NOUN	I
of	O	ADP	O
HCMV	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
endemic	O	ADJ	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
serves	O	VERB	O
as	O	ADP	O
a	O	DET	O
marker	O	NOUN	B
for	O	ADP	O
metastatic	O	ADJ	B
potential	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
skin	O	NOUN	O
cancer	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
assessed	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
9	O	NUM	O
keratoacanthomas	O	NOUN	B
(	O	PUNCT	O
KAs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
26	O	NUM	O
squamous	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
SCCs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
25	O	NUM	O
basal	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
BCCs	O	NOUN	B
)	O	PUNCT	O
using	O	VERB	O
immunohistochemistry	O	NOUN	B
.	O	PUNCT	O


And	O	CCONJ	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
difference	O	NOUN	O
in	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
between	O	ADP	O
SCC	O	NOUN	B
with	O	ADP	O
metastasis	O	NOUN	B
and	O	CCONJ	O
SCC	O	NOUN	B
without	O	ADP	O
metastasis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
major	B-DNA	ADJ	B
histocompatibility	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
MHC	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
class	I-DNA	NOUN	B
II	I-DNA	NUM	I
genes	I-DNA	NOUN	I
encode	O	VERB	B
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
proteins	I-protein	NOUN	O
that	O	PRON	O
bind	O	VERB	B
antigenic	O	ADJ	B
peptide	O	NOUN	I
for	O	ADP	O
presentation	O	NOUN	B
to	O	PART	O
T-cells	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
class	B-protein	NOUN	B
II	I-protein	NUM	I
proteins	I-protein	NOUN	I
are	O	AUX	O
expressed	O	VERB	B
constitutively	O	ADV	B
on	O	ADP	O
B-cells	B-cell_type	NOUN	B
and	O	CCONJ	O
EBV-transformed	B-cell_line	ADJ	B
B-cells	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
inducible	O	ADJ	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
on	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
cell	B-cell_type	NOUN	B
types	I-cell_type	NOUN	I
.	O	PUNCT	O


RB-defective	B-cell_line	ADJ	B
tumor	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
are	O	AUX	O
non-inducible	O	ADJ	B
for	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
very	O	ADV	O
weakly	O	ADV	O
inducible	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
transfection	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
different	O	ADJ	O
lines	O	NOUN	B
with	O	ADP	O
RB	B-DNA	NOUN	B
expression	I-DNA	NOUN	O
vectors	I-DNA	NOUN	O
re-establishes	O	VERB	B
or	O	CCONJ	O
substantially	O	ADV	O
enhances	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
inducibility	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
matrix-bound	O	ADJ	I
RB	B-protein	NOUN	I
was	O	AUX	O
detectable	O	ADJ	B
in	O	ADP	O
all	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
loss	O	NOUN	B
of	O	ADP	O
RB	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
responsible	O	ADJ	O
for	O	ADP	O
decreased	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
expression	O	NOUN	B
in	O	ADP	O
these	O	DET	O
lines	O	NOUN	B
.	O	PUNCT	O


CIITA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
normally	O	ADV	O
inducible	O	ADJ	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
non-inducible	I-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
RB-defective	I-cell_line	ADJ	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
one	O	NUM	O
line	O	NOUN	O
,	O	PUNCT	O
re-expression	O	NOUN	B
of	O	ADP	O
RB	B-protein	NOUN	B
has	O	AUX	O
no	O	DET	O
effect	O	NOUN	O
on	O	ADP	O
CIITA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
induction	O	NOUN	O
levels	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
natural	I-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
with	O	ADP	O
IL-12	B-protein	NOUN	B
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Janus	B-protein	NOUN	B
family	I-protein	NOUN	I
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
JAK2	B-protein	NOUN	I
and	O	CCONJ	O
Tyk2	B-protein	NOUN	B
,	O	PUNCT	O
implicating	O	VERB	O
these	O	DET	O
kinases	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
immediate	O	ADJ	B
biochemical	O	ADJ	B
response	O	NOUN	O
to	O	PART	O
IL-12	B-protein	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
known	O	VERB	O
as	O	ADP	O
STATs	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
tyrosine	O	NOUN	B
phosphorylated	O	ADJ	B
and	O	CCONJ	O
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
hematopoietin	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
activate	O	VERB	B
JAK	B-protein	NOUN	B
kinases	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
IL-12	B-protein	NOUN	B
stimulates	O	VERB	B
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
complex	I-protein	NOUN	I
that	O	PRON	O
recognizes	O	VERB	O
a	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
previously	O	ADV	O
shown	O	VERB	O
to	O	PART	O
bind	O	VERB	B
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
complex	O	NOUN	B
contains	O	VERB	O
STAT4	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
adaptive	O	ADJ	B
mechanisms	O	NOUN	I
which	O	DET	O
occur	O	VERB	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
in	O	ADP	O
glucocorticoid	O	NOUN	B
target	O	NOUN	B
tissues	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
sepsis	O	NOUN	B
or	O	CCONJ	O
septic	O	ADJ	B
shock	O	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Hypercortisolaemia	O	NOUN	B
,	O	PUNCT	O
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
decreased	O	VERB	B
affinity	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
decreased	O	VERB	B
binding	O	NOUN	B
capacity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
weak	O	ADJ	B
but	O	CCONJ	O
significant	O	ADJ	O
negative	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
body	O	NOUN	B
temperature	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
group	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
There	O	PRON	O
is	O	AUX	O
no	O	DET	O
obvious	O	ADJ	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
by	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
concentrations	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Integrin-mediated	O	ADJ	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	I
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
message	O	NOUN	O
induction	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
cytoplasmic	B-protein	ADJ	B
tyrosine	I-protein	NOUN	B
kinases	I-protein	NOUN	I
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
aspect	O	NOUN	O
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
integrins	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
integrin	B-protein	NOUN	B
ligation	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
subunits	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
driven	O	VERB	O
by	O	ADP	O
a	O	DET	O
promoter	B-DNA	NOUN	B
containing	O	VERB	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
mRNAs	B-RNA	NOUN	B
for	O	ADP	O
immediate-early	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
cytokine	B-protein	NOUN	B
interleukin	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
beta	I-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Syk	B-protein	NOUN	B
tyrosine	O	NOUN	I
kinase	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
component	O	NOUN	B
of	O	ADP	O
an	O	DET	O
integrin	B-protein	NOUN	B
signaling	O	NOUN	I
pathway	O	NOUN	I
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
to	O	PART	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
messages	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
if	O	SCONJ	O
New	O	ADJ	B
World	O	NOUN	I
primates	O	NOUN	I
express	O	VERB	O
an	O	DET	O
inhibitor	O	NOUN	B
that	O	PRON	O
influences	O	VERB	B
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
GR	B-protein	NOUN	B
)	O	PUNCT	O
binding	O	NOUN	B
characteristics	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
dexamethasone	O	NOUN	B
binding	O	NOUN	B
in	O	ADP	O
cytosol	O	NOUN	B
prepared	O	VERB	O
from	O	ADP	O
B95-8	B-cell_line	NOUN	B
lymphoid	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
cotton	O	NOUN	B
top	O	NOUN	O
tamarin	O	NOUN	O
(	O	PUNCT	O
Saguinus	O	X	B
oedipus	O	X	I
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
cytosol	O	NOUN	B
prepared	O	VERB	O
from	O	ADP	O
human	O	ADJ	B
or	O	CCONJ	O
rat	O	NOUN	B
tissues	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inhibitory	O	ADJ	B
activity	O	NOUN	O
was	O	AUX	O
heat	O	NOUN	B
labile	O	ADJ	I
and	O	CCONJ	O
trypsin	B-protein	NOUN	B
sensitive	O	ADJ	B
.	O	PUNCT	O


Disruption	O	NOUN	B
of	O	ADP	O
a	O	DET	O
GATA	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
Duffy	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
abolishes	O	VERB	O
erythroid	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
Duffy-negative	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


With	O	ADP	O
the	O	DET	O
recent	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
FY*A	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
FY*B	I-DNA	NOUN	B
alleles	I-DNA	NOUN	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
provide	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Duffy	O	NOUN	B
blood	O	NOUN	I
group	O	NOUN	I
system	O	NOUN	I
and	O	CCONJ	O
an	O	DET	O
explanation	O	NOUN	B
for	O	ADP	O
the	O	DET	O
erythroid-specific	O	ADJ	B
repression	O	NOUN	I
of	O	ADP	O
the	O	DET	O
DARC	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
Duffy-negative	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
pokeweed	B-protein	NOUN	B
mitogen	I-protein	NOUN	I
(	O	PUNCT	O
PWM	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
early	B-DNA	ADJ	B
growth	I-DNA	NOUN	O
response-1	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
(	O	PUNCT	O
EGR-1	B-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
normal	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
assays	O	NOUN	O
with	O	ADP	O
EGR-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
fragments	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
demonstrated	O	VERB	O
that	O	SCONJ	O
PWM	B-protein	NOUN	B
induced	O	ADJ	B
EGR-1	B-DNA	NOUN	B
transcription	O	NOUN	B
is	O	AUX	O
conferred	O	VERB	O
by	O	ADP	O
the	O	DET	O
CArG	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
(	O	PUNCT	O
C	B-DNA	NOUN	O
C	I-DNA	NOUN	O
[	I-DNA	PUNCT	O
AT	I-DNA	NOUN	O
]	I-DNA	PUNCT	O
6GG	I-DNA	ADJ	O
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
EGR-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
conserved	B-DNA	VERB	O
motif	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
expressed	O	VERB	B
by	O	ADP	O
human	B-cell_line	ADJ	B
Th2-type	I-cell_line	ADJ	B
lymphocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


This	O	DET	O
suggest	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
may	O	AUX	O
interact	O	VERB	B
with	O	ADP	O
a	O	DET	O
new	O	ADJ	O
family	O	NOUN	B
of	O	ADP	O
trans-acting	B-protein	ADJ	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Considering	O	VERB	O
the	O	DET	O
strong	O	ADJ	O
positive	O	ADJ	B
regulatory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
this	O	DET	O
element	B-DNA	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
presence	O	NOUN	B
in	O	ADP	O
several	O	ADJ	O
T-cell-expressed	B-DNA	ADJ	B
cytokine	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
may	O	AUX	O
be	O	AUX	O
crucial	O	ADJ	O
to	O	PART	O
the	O	DET	O
coordinated	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cytokines	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
helper	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


A	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
lymphoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
PEER	B-cell_line	NOUN	B
,	O	PUNCT	O
dies	O	VERB	B
by	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
gene	B-DNA	NOUN	B
,	O	PUNCT	O
TINUR	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
cloned	O	VERB	B
from	O	ADP	O
apoptotic	B-cell_line	ADJ	B
PEER	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


TINUR	B-DNA	NOUN	B
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
NGFI-B/nur77	B-protein	NOUN	B
family	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
an	O	DET	O
orphan	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
by	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	I
TNF	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
mobilization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	B-protein	ADJ	I
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Since	O	SCONJ	O
salicylates	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
preventing	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
inhibitor	O	NOUN	B
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
a	O	DET	O
potential	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
this	O	DET	O
pathway	O	NOUN	B
by	O	ADP	O
acetylsalicylate	O	NOUN	B
(	O	PUNCT	O
aspirin	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
human	B-cell_line	ADJ	B
umbilical	I-cell_line	ADJ	I
vein	I-cell_line	NOUN	I
endothelial	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
HUVECs	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
surface	O	NOUN	O
expression	O	NOUN	B
by	O	ADP	O
TNF	B-protein	NOUN	B
was	O	AUX	O
dose-dependently	O	ADV	O
reduced	O	VERB	B
by	O	ADP	O
aspirin	O	NOUN	B
over	O	ADP	O
the	O	DET	O
same	O	ADJ	O
range	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
induction	O	NOUN	B
of	O	ADP	O
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
ICAM-1	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
hardly	O	ADV	O
affected	O	VERB	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Our	O	PRON	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
aspirin	O	NOUN	B
inhibits	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
mobilization	O	NOUN	B
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
subsequent	O	ADJ	O
monocyte	O	NOUN	B
adhesion	O	NOUN	I
in	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
by	O	ADP	O
TNF	B-protein	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
providing	O	VERB	O
an	O	DET	O
additional	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
therapeutic	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
aspirin	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
by	O	ADP	O
phosphatase	B-protein	NOUN	B
inhibitors	O	NOUN	I
involves	O	VERB	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
at	O	ADP	O
phosphatase	B-protein	NOUN	B
2A-sensitive	I-protein	ADJ	I
sites	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
serine/threonine	B-protein	NOUN	B
phosphatases	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
phosphorylation	O	NOUN	B
was	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
phosphorylated	B-protein	ADJ	B
I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
from	O	ADP	O
calyculin	B-cell_line	NOUN	B
A-treated	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
that	O	DET	O
from	O	ADP	O
TNF-alpha-stimulated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
sensitive	O	ADJ	B
to	O	PART	O
PP-2A	B-protein	NOUN	B
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
fundamental	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
induced	O	VERB	B
by	O	ADP	O
the	O	DET	O
two	O	NUM	O
different	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inducers	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
,	O	PUNCT	O
mediated	O	VERB	O
through	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
TNF-alpha	B-protein	NOUN	B
-inducible	O	ADJ	O
and	O	CCONJ	O
the	O	DET	O
PP-2A-opposing	B-protein	ADJ	B
kinases	I-protein	NOUN	I
,	O	PUNCT	O
may	O	AUX	O
serve	O	VERB	O
to	O	PART	O
target	O	VERB	B
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
for	O	ADP	O
proteasome	B-protein	NOUN	B
-mediated	O	ADJ	O
degradation	O	NOUN	B
.	O	PUNCT	O


Sp1	B-protein	NOUN	B
functions	O	VERB	B
in	O	ADP	O
a	O	DET	O
chromatin	B-DNA	NOUN	B
-dependent	O	ADJ	O
manner	O	NOUN	O
to	O	PART	O
augment	O	VERB	O
human	B-DNA	ADJ	B
alpha-globin	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
alpha-globin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
highly	O	ADV	O
G	O	NOUN	O
+	O	CCONJ	O
C	O	NOUN	O
rich	O	ADJ	O
and	O	CCONJ	O
contains	O	VERB	O
multiple	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
consensus	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
Sp1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
upon	O	SCONJ	O
stable	O	ADJ	B
integration	O	NOUN	B
into	O	ADP	O
chromatin	B-DNA	NOUN	B
,	O	PUNCT	O
deletion	O	NOUN	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
causes	O	VERB	O
a	O	DET	O
nearly	O	ADV	O
90	O	NUM	O
%	O	NOUN	O
decrease	O	NOUN	B
in	O	ADP	O
promoter	O	NOUN	B
activity	O	NOUN	I
compared	O	VERB	B
with	O	ADP	O
expression	O	NOUN	B
from	O	ADP	O
an	O	DET	O
alpha-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
retaining	O	VERB	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
earlier	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
with	O	ADP	O
SEA	O	NOUN	B
presented	O	VERB	O
on	O	ADP	O
Chinese	B-cell_line	ADJ	B
hamster	I-cell_line	NOUN	I
ovary	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
CHO	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-DR	I-cell_line	NOUN	O
transfectants	I-cell_line	NOUN	B
coexpressing	O	VERB	B
either	O	CCONJ	O
B7	B-protein	NOUN	B
or	O	CCONJ	O
LFA-3	B-protein	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
distinct	O	ADJ	O
cytokine	B-protein	NOUN	B
profiles	O	NOUN	I
.	O	PUNCT	O


LFA-3	B-protein	NOUN	B
induced	O	VERB	B
moderate	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
influence	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
B7	B-protein	NOUN	B
costimulation	O	NOUN	B
strongly	O	ADV	O
induced	O	VERB	B
both	O	CCONJ	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
substantially	O	ADV	O
enhanced	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
CHO-DR/B7/LFA-3	B-cell_line	NOUN	O
triple	I-cell_line	ADJ	B
transfectant	I-cell_line	NOUN	I
induced	O	VERB	B
a	O	DET	O
further	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	B-protein	NOUN	I
proteins	I-protein	NOUN	I
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
double	B-cell_line	ADJ	O
transfectants	I-cell_line	NOUN	B
.	O	PUNCT	O


The	O	DET	O
AP-1	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
contained	O	VERB	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
Jun-D	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Fra-1	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
marginal	O	ADJ	B
amounts	O	NOUN	O
of	O	ADP	O
Jun-B	B-protein	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
recognizes	O	VERB	O
DNA	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
BSAP	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
dioxin-mediated	O	ADJ	O
alteration	O	NOUN	B
of	O	ADP	O
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
gel	O	NOUN	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
complex	I-protein	NOUN	I
in	O	ADP	O
IM-9	O	NOUN	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
that	O	PRON	O
by	O	ADP	O
several	O	ADJ	O
criteria	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
AhR	B-protein	NOUN	B
could	O	AUX	O
interfere	O	VERB	O
with	O	ADP	O
BSAP	B-protein	NOUN	B
-stimulated	O	ADJ	O
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	B
by	O	ADP	O
competition	O	NOUN	B
for	O	ADP	O
a	O	DET	O
common	O	ADJ	O
DNA	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Inhibitory	O	ADJ	B
action	O	NOUN	O
of	O	ADP	O
nm23	B-protein	NOUN	B
proteins	I-protein	NOUN	I
on	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
leukemia	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
identified	O	VERB	B
a	O	DET	O
differentiation	B-protein	NOUN	B
inhibitory	I-protein	ADJ	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
I-factor	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
mouse	B-cell_line	NOUN	B
myeloid	I-cell_line	ADJ	B
leukemia	I-cell_line	NOUN	I
M1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
as	O	ADP	O
a	O	DET	O
murine	B-protein	ADJ	B
homolog	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
nm23-H2	I-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
.	O	PUNCT	O


nm23	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
encode	O	VERB	B
proteins	O	NOUN	B
that	O	PRON	O
participate	O	VERB	B
in	O	ADP	O
tumor	O	NOUN	B
metastasis	O	NOUN	I
regulation	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
various	O	ADJ	O
fundamental	O	ADJ	O
cellular	O	ADJ	B
processes	O	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
their	O	PRON	O
mechanisms	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
are	O	AUX	O
still	O	ADV	O
unknown	O	ADJ	O
.	O	PUNCT	O


Lipopolysaccharide-induced	O	ADJ	B
E-selectin	B-protein	NOUN	B
expression	O	NOUN	B
requires	O	VERB	O
continuous	O	ADJ	B
presence	O	NOUN	B
of	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
bactericidal/permeability-increasing	B-protein	ADJ	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


rBPI21	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
recombinant	B-protein	ADJ	B
N-terminal	I-protein	ADJ	O
fragment	I-protein	NOUN	O
of	O	ADP	O
human	B-protein	ADJ	B
bactericidal/permeability-increasing	I-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
BPI	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
inhibited	O	VERB	B
LPS-induced	O	ADJ	B
E-selectin	B-protein	NOUN	B
expression	O	NOUN	B
when	O	SCONJ	O
added	O	VERB	O
at	O	ADP	O
the	O	DET	O
same	O	ADJ	O
time	O	NOUN	O
as	O	ADP	O
,	O	PUNCT	O
and	O	CCONJ	O
up	O	ADP	O
to	O	PART	O
6	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
,	O	PUNCT	O
LPS	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
to	O	PART	O
4	O	NUM	O
h	O	NOUN	O
following	O	VERB	O
LPS	O	NOUN	B
addition	O	NOUN	O
to	O	PART	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
when	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
already	O	ADV	O
activated	O	VERB	B
,	O	PUNCT	O
addition	O	NOUN	O
of	O	ADP	O
rBPI21	B-protein	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
marked	O	ADJ	O
reduction	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
detectable	O	ADJ	B
at	O	ADP	O
4	O	NUM	O
or	O	CCONJ	O
6	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


So	O	ADV	O
called	O	VERB	O
costimulatory	O	ADJ	B
signals	O	NOUN	B
,	O	PUNCT	O
mediated	O	VERB	O
by	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
surface	O	NOUN	I
interactions	O	NOUN	B
or	O	CCONJ	O
soluble	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
produced	O	VERB	O
by	O	ADP	O
antigen	B-cell_type	NOUN	B
presenting	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
also	O	ADV	O
required	O	VERB	O
for	O	ADP	O
complete	O	ADJ	B
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
promoter	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
enhancer	I-DNA	NOUN	B
regions	I-DNA	NOUN	I
are	O	AUX	O
mainly	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
by	O	ADP	O
TCR	B-protein	NOUN	B
signals	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
well	O	ADV	O
described	O	VERB	O
for	O	ADP	O
interleukin-2	O	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
IL-4	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
HTLV-1	B-protein	NOUN	B
transactivator	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
tax	B-protein	NOUN	O
,	O	PUNCT	O
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
costimulatory	O	ADJ	B
signal	O	NOUN	I
for	O	ADP	O
GM-CSF	O	NOUN	B
and	O	CCONJ	O
IL-2	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
cooperate	O	VERB	O
with	O	ADP	O
TCR	B-protein	NOUN	B
signals	O	NOUN	B
to	O	PART	O
mediate	O	VERB	O
high	O	ADJ	O
level	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
observation	O	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
both	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
respond	O	VERB	O
to	O	PART	O
TCR	B-protein	NOUN	B
signals	O	NOUN	B
via	O	ADP	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
implies	O	VERB	O
a	O	DET	O
high	O	ADJ	O
degree	O	NOUN	B
of	O	ADP	O
conservation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
10	O	NUM	O
microM	O	NOUN	O
,	O	PUNCT	O
both	O	DET	O
compounds	O	NOUN	B
inhibited	O	VERB	B
IL-2	O	NOUN	B
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
levels	O	NOUN	I
in	O	ADP	O
the	O	DET	O
NFAT-1-linked	B-cell_line	ADJ	O
lac-Z	I-cell_line	NOUN	B
transfectants	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
human	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
compounds	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
mixed	O	ADJ	O
lymphocyte	O	NOUN	O
reaction	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
inhibition	O	NOUN	B
was	O	AUX	O
reversed	O	VERB	O
by	O	ADP	O
exogenous	O	ADJ	B
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
calcium-independent	B-protein	ADJ	B
anti-CD28	I-protein	ADJ	B
Ab	I-protein	NOUN	I
and	O	CCONJ	O
PMA-induced	O	ADJ	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
was	O	AUX	O
resistant	O	ADJ	B
.	O	PUNCT	O


By	O	ADP	O
these	O	DET	O
functional	O	ADJ	B
criteria	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
believe	O	VERB	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
two	O	NUM	O
structurally	O	ADV	B
distinct	O	ADJ	O
,	O	PUNCT	O
novel	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
-1-mediated	O	ADJ	O
transcription	O	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
nuclear	O	ADJ	B
runoff	O	ADJ	I
experiments	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
subunit	O	NOUN	B
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
B2	B-protein	NOUN	B
isoform	I-protein	NOUN	I
(	O	PUNCT	O
Mr	O	NOUN	O
=	O	ADJ	O
56	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
amplified	O	VERB	B
primarily	O	ADV	O
by	O	ADP	O
transcriptional	O	ADJ	B
means	O	NOUN	I
.	O	PUNCT	O


Isolation	O	NOUN	B
and	O	CCONJ	O
sequencing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
first	B-DNA	ADJ	O
exon	I-DNA	NOUN	B
and	O	CCONJ	O
5'-flanking	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
reveal	O	VERB	O
a	O	DET	O
TATA-less	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
with	O	ADP	O
a	O	DET	O
high	O	ADJ	O
G	O	NOUN	O
+	O	CCONJ	O
C	O	NOUN	B
content	O	NOUN	B
.	O	PUNCT	O


Okadaic	O	ADJ	B
acid	O	NOUN	I
augments	O	VERB	B
PMA-	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
calcium-mediated	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
c-fos	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
has	O	AUX	O
little	O	ADJ	O
or	O	CCONJ	O
no	O	DET	B
effect	O	NOUN	I
when	O	SCONJ	O
combined	O	VERB	B
with	O	ADP	O
cAMP	O	NOUN	B
.	O	PUNCT	O


IL-10	O	NOUN	B
induces	O	VERB	B
the	O	DET	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
tyk2	B-protein	NOUN	B
and	O	CCONJ	O
Jak1	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
differential	O	ADJ	B
assembly	O	NOUN	I
of	O	ADP	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
complexes	I-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
IL-10	B-protein	NOUN	B
stimulates	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	O	CCONJ	O
activators	B-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	B
,	O	PUNCT	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
differential	O	ADJ	B
manner	O	NOUN	O
such	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
relative	O	ADJ	O
formation	O	NOUN	B
of	O	ADP	O
homo-	B-protein	ADJ	B
and	I-protein	CCONJ	O
heterodimers	I-protein	NOUN	B
varies	O	VERB	O
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Selective	O	ADJ	O
modulation	O	NOUN	B
of	O	ADP	O
immune	O	ADJ	B
responsiveness	O	NOUN	I
by	O	ADP	O
IL-10	B-protein	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
may	O	AUX	O
result	O	VERB	O
in	O	ADP	O
part	O	NOUN	O
from	O	ADP	O
the	O	DET	O
differential	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
protein	I-protein	NOUN	I
pairs	I-protein	NOUN	B
.	O	PUNCT	O


All	O	DET	O
the	O	DET	O
markers	O	NOUN	B
considered	O	VERB	O
were	O	AUX	O
sufficiently	O	ADV	O
sensitive	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
among	O	ADP	O
them	O	PRON	O
,	O	PUNCT	O
Platelet	B-protein	NOUN	B
Factor	I-protein	NOUN	I
IV	I-protein	NUM	I
was	O	AUX	O
the	O	DET	O
most	O	ADV	O
reliable	O	ADJ	O
to	O	PART	O
the	O	DET	O
hormonal	O	ADJ	B
ovulatory	O	ADJ	O
situation	O	NOUN	O
.	O	PUNCT	O


They	O	PRON	O
also	O	ADV	O
display	O	VERB	O
constitutively	O	ADV	B
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
CD3	B-protein	NOUN	B
zeta	I-protein	NOUN	I
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
novel	O	ADJ	O
NF-AT-binding	B-protein	NOUN	B
factor	I-protein	NOUN	I
is	O	AUX	O
rapidly	O	ADV	O
down-regulated	O	VERB	B
in	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
persists	O	VERB	O
at	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
Ipr	B-cell_line	NOUN	B
CD4-8-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Cross-linking	O	NOUN	B
of	O	ADP	O
CD30	B-protein	NOUN	B
induces	O	VERB	B
HIV	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
chronically	O	ADV	B
infected	O	ADJ	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
cross-linking	O	ADJ	B
CD30	B-protein	NOUN	B
with	O	ADP	O
an	O	DET	O
anti-	O	NOUN	O
CD30	B-protein	NOUN	B
-specific	O	ADJ	O
monoclonal	O	ADJ	B
antibody	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mimics	O	VERB	B
the	O	DET	O
described	O	VERB	O
biological	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CD30	B-protein	NOUN	B
ligand	I-protein	NOUN	I
(	O	PUNCT	O
CD30L	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
CD30	B-protein	NOUN	B
-CD30L	B-protein	ADJ	O
interactions	O	NOUN	B
mediate	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
a	O	DET	O
kappa	O	NOUN	O
B-dependent	O	ADJ	B
pathway	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
TNF	B-protein	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
CIITA	B-DNA	NOUN	B
is	O	AUX	O
an	O	DET	O
MHC	B-DNA	NOUN	B
class	I-DNA	NOUN	O
II	I-DNA	NUM	O
gene-specific	I-DNA	ADJ	B
transcription	I-DNA	NOUN	I
activator	I-DNA	NOUN	I
.	O	PUNCT	O


Monocyte	O	NOUN	B
tethering	O	NOUN	I
by	O	ADP	O
P-selectin	B-protein	NOUN	B
regulates	O	VERB	B
monocyte	B-protein	NOUN	B
chemotactic	I-protein	ADJ	I
protein-1	I-protein	NOUN	I
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
secretion	O	NOUN	I
.	O	PUNCT	O


Adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	B
that	O	PRON	O
tether	O	VERB	O
circulating	B-cell_type	VERB	B
leukocytes	I-cell_type	NOUN	B
to	O	PART	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
may	O	AUX	O
also	O	ADV	O
transduce	O	VERB	B
or	O	CCONJ	O
modulate	O	VERB	B
outside-in	O	ADJ	B
signals	O	NOUN	I
for	O	ADP	O
cellular	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
providing	O	VERB	O
an	O	DET	O
initial	O	ADJ	O
regulatory	O	ADJ	B
point	O	NOUN	I
in	O	ADP	O
the	O	DET	O
inflammatory	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


Increased	O	VERB	B
cytokine	O	NOUN	B
secretion	O	NOUN	I
was	O	AUX	O
specifically	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
G1	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
anti-P-selectin	B-protein	ADJ	B
mAb	I-protein	NOUN	B
that	O	PRON	O
prevents	O	VERB	B
P-selectin	B-protein	NOUN	B
from	O	ADP	O
binding	O	VERB	B
to	O	PART	O
its	O	PRON	O
ligand	O	NOUN	B
(	O	PUNCT	O
P-selectin	B-protein	NOUN	O
glycoprotein	I-protein	NOUN	O
ligand-1	I-protein	NOUN	O
)	O	PUNCT	O
on	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
have	O	AUX	O
defined	O	VERB	O
the	O	DET	O
regulatory	O	ADJ	B
roles	O	NOUN	I
of	O	ADP	O
the	O	DET	O
different	O	ADJ	O
HS-40	B-DNA	NOUN	B
motifs	I-DNA	NOUN	B
.	O	PUNCT	O


Nitric	O	ADJ	B
oxide-stimulated	O	ADJ	O
guanine	O	NOUN	O
nucleotide	O	NOUN	O
exchange	O	NOUN	O
on	O	ADP	O
p21ras	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
identify	O	VERB	O
p21ras	B-DNA	NOUN	B
as	O	ADP	O
a	O	DET	O
target	O	NOUN	B
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
cell	O	NOUN	B
.	O	PUNCT	O


Latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein-1	I-protein	NOUN	I
induces	O	VERB	O
cyclin	B-protein	NOUN	B
D2	I-protein	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
pRb	B-protein	NOUN	B
hyperphosphorylation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
loss	O	NOUN	B
of	O	ADP	O
TGF-beta	B-protein	NOUN	B
1	I-protein	NUM	I
-mediated	O	ADJ	O
growth	O	NOUN	B
inhibition	O	NOUN	I
in	O	ADP	O
EBV-positive	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Six	O	NUM	O
to	O	PART	O
8	O	NUM	O
weeks	O	NOUN	B
after	O	ADP	O
subtotal	O	ADJ	B
thyroidectomy	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
'	O	PART	O
PBMC	B-cell_type	NOUN	B
responding	O	VERB	B
to	O	PART	O
any	O	DET	O
peptide	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
average	O	ADJ	B
number	O	NOUN	O
of	O	ADP	O
recognized	O	VERB	O
peptides	O	NOUN	B
decreased	O	VERB	B
.	O	PUNCT	O


Responses	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
GD	O	NOUN	B
,	O	PUNCT	O
maintained	O	VERB	B
euthyroid	O	ADJ	B
on	O	ADP	O
ATD	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
lower	O	ADJ	O
than	O	ADP	O
those	O	DET	O
before	O	ADP	O
surgery	O	NOUN	B
or	O	CCONJ	O
RAI	O	NOUN	B
therapy	O	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
events	O	NOUN	I
that	O	PRON	O
underlie	O	VERB	O
the	O	DET	O
well-defined	O	ADJ	O
phenotypic	O	ADJ	B
changes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
differentiating	B-cell_type	VERB	B
thymocyte	I-cell_type	NOUN	B
are	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
PuF	B-DNA	NOUN	B
site	I-DNA	NOUN	I
on	O	ADP	O
the	O	DET	O
silent	B-DNA	ADJ	B
normal	I-DNA	ADJ	O
c-myc	I-DNA	NOUN	O
allele	I-DNA	NOUN	O
was	O	AUX	O
unoccupied	O	ADJ	B
.	O	PUNCT	O


Interaction	O	NOUN	B
between	O	ADP	O
the	O	DET	O
stage	B-DNA	NOUN	B
selector	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
SSE	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
gamma-globin	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
hypersensitivity	B-DNA	NOUN	B
site	I-DNA	NOUN	I
2	I-DNA	NUM	I
in	O	ADP	O
the	O	DET	O
locus	B-DNA	NOUN	B
control	I-DNA	NOUN	I
region	I-DNA	NOUN	I
partly	O	ADV	O
mediates	O	VERB	O
the	O	DET	O
competitive	O	ADJ	B
silencing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
fetal	O	ADJ	B
developmental	O	ADJ	I
stage	O	NOUN	I
.	O	PUNCT	O


Mutation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
20-base	O	ADJ	O
pair	O	NOUN	O
sequence	O	NOUN	O
of	O	ADP	O
the	O	DET	O
gamma-gene	B-DNA	NOUN	B
5'-untranslated	I-DNA	ADJ	I
region	I-DNA	NOUN	I
(	O	PUNCT	O
UTR	B-DNA	NOUN	B
)	O	PUNCT	O
led	O	VERB	O
to	O	PART	O
derepression	O	NOUN	B
of	O	ADP	O
beta-promoter	B-DNA	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


Growth	O	NOUN	B
regulation	O	NOUN	I
and	O	CCONJ	O
cellular	O	ADJ	B
changes	O	NOUN	I
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
prostatic	I-cell_line	ADJ	O
cancer	I-cell_line	NOUN	O
LNCaP	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
as	O	ADP	O
induced	O	VERB	B
by	O	ADP	O
T	O	NOUN	B
lymphocyte-conditioned	O	ADJ	I
medium	O	NOUN	I
.	O	PUNCT	O


Activated	O	VERB	B
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
were	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
providing	O	VERB	O
the	O	DET	O
modulating	O	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
clarify	O	VERB	O
properties	O	NOUN	B
of	O	ADP	O
the	O	DET	O
blast	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
M7	O	NOUN	B
and	O	CCONJ	O
TMD	O	NOUN	B
cases	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
erythroid	O	ADJ	B
markers	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
blasts	B-cell_type	NOUN	B
from	O	ADP	O
six	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
M7	O	NOUN	B
and	O	CCONJ	O
seven	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
TMD	O	NOUN	B
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
found	O	VERB	O
a	O	DET	O
high	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
human	B-RNA	ADJ	B
Ah	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
TCDD	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
of	O	ADP	O
individuals	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	B-cell_type	ADJ	B
virus	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
EBV	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
-infected	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	B
may	O	AUX	O
sustain	O	VERB	O
three	O	NUM	O
distinct	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
virus	O	NOUN	B
latency	O	NOUN	B
.	O	PUNCT	O


Detection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chromosome	B-RNA	NOUN	B
16	I-RNA	NUM	O
CBF	I-RNA	NOUN	B
beta-MYH11	I-RNA	NOUN	B
fusion	I-RNA	NOUN	B
transcript	I-RNA	NOUN	I
in	O	ADP	O
myelomonocytic	O	ADJ	B
leukemias	O	NOUN	I
.	O	PUNCT	O


Fifty-three	O	NUM	O
cases	O	NOUN	B
(	O	PUNCT	O
11	O	NUM	O
AML	O	NOUN	B
M4Eo	O	NOUN	B
;	O	PUNCT	O
1	O	NUM	O
AML	O	NOUN	B
M4	O	NOUN	B
with	O	ADP	O
atypical	B-cell_type	ADJ	B
abnormal	I-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	O
(	O	PUNCT	O
AML	O	NOUN	B
M4	O	NOUN	I
``	O	PUNCT	O
Eo	O	NOUN	B
''	O	PUNCT	I
)	O	PUNCT	O
;	O	PUNCT	O
29	O	NUM	O
AML	O	NOUN	B
M4	O	NOUN	O
;	O	PUNCT	O
8	O	NUM	O
AML	O	NOUN	B
M5	O	NOUN	O
;	O	PUNCT	O
3	O	NUM	O
CMML	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
AML	O	NOUN	B
M2	O	NOUN	B
with	O	ADP	O
eosinophilia	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
glucocorticoids	O	NOUN	B
on	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
conclusion	O	NOUN	O
is	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
corticoid	O	NOUN	B
resistance	O	NOUN	B
in	O	ADP	O
mouse	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
human	I-cell_line	ADJ	B
lymphoma	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
in	O	ADP	O
culture	O	NOUN	B
.	O	PUNCT	O


